DaShenLin Pharmaceutical Group Co Ltd
DaShenLin Pharmaceutical Group's GHG Emissions Data Preview
In 2024, DaShenLin Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, DaShenLin Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Verified Sources Behind DaShenLin Pharmaceutical Group’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore DaShenLin Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.
Insights into DaShenLin Pharmaceutical Group's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of DaShenLin Pharmaceutical Group amounted to 19,303.07 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
DaShenLin Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are DaShenLin Pharmaceutical Group's Scope 1 emissions?
In 2024, the total Scope 1 emissions of DaShenLin Pharmaceutical Group were 5,220.48 metric tons of CO₂ equivalent (tCO₂e).a
What are DaShenLin Pharmaceutical Group's Scope 2 emissions?
In 2024, DaShenLin Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 14,082.59 tCO₂e without specifying the calculation method.a
What methodology does DaShenLin Pharmaceutical Group use for Scope 2 reporting?
In 2024, DaShenLin Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology.a
DaShenLin Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into DaShenLin Pharmaceutical Group’s GHG Emissions Intensity Compared to Industry Peers
In 2024, DaShenLin Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 5,220.48 tCO₂e and total revenues of USD 3,631 millions. This translates into an emissions intensity of 1.44 tCO₂e per millions USD.a
DaShenLin Pharmaceutical Group's Scope 1 Emissions Intensity Compared to Peers
How does DaShenLin Pharmaceutical Group's GHG emissions intensity compare to its peers?
In 2024, DaShenLin Pharmaceutical Group reported a Scope 1 emissions intensity of 1.44 tCO₂e per millions USD. Compared to the peer group median of 9.75, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does DaShenLin Pharmaceutical Group rank on GHG emissions intensity within its industry?
In 2024, DaShenLin Pharmaceutical Group ranked 5 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places DaShenLin Pharmaceutical Group among the top performers, with one of the lowest emissions intensities relative to peers.a